Gene · 1442
Papers1,713
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,713
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dynamic evaluation of postoperative survival in pancreatic ductal adenocarcinoma. | Medicine (Baltimore) | 2025 | 40128033 | PubTator, text mining | PubMed |
| The neutrophil antigen 3a/b polymorphism in SLC44A2 unexpectedly encodes the Csa/Csb red cell antigens. | Blood | 2025 | 40090003 | PubTator, text mining | PubMed |
| A patenting perspective of fat mass and obesity associated protein (FTO) inhibitors: 2017-present. | Expert Opin Ther Pat | 2025 | 40052926 | PubTator, text mining | PubMed |
| Clock Proteins Have the Potential to Improve Term Delivery Date Prediction: A Proof-of-Concept Study. | Life (Basel) | 2025 | 40003633 | PubTator, text mining | PubMed |
| The Ataxia-telangiectasia mutated (ATM) is the most important gene for repairing the DNA in Myelodysplastic Neoplasm. | DNA Repair (Amst) | 2025 | 39874624 | PubTator, text mining | PubMed |
| Discrete placental gene expression signatures accompany diabetic disease classifications during pregnancy. | Am J Obstet Gynecol | 2025 | 38763341 | PubTator, text mining | PubMed |
| RETRACTED: Refining molecular subtypes and risk stratification of ovarian cancer through multi-omics consensus portfolio and machine learning. | Environ Toxicol | 2025 | 38480676 | PubTator, text mining | PubMed |
| Study on the structural stability of partial cable-stayed bridges with multiple towers and high piers during construction. | PLoS One | 2024 | 39666617 | PubTator, text mining | PubMed |
New synthetic chitosan Schiff bases bearing pyranoquinolinone or benzonaphthyridine and their silver nanoparticles derivatives with potential activity as antioxidant and molecular docking study for EGFR inhibitors. | RSC Adv | 2024 | 39309650 | PubTator, text mining | PubMed |
| Learning to quantify uncertainty in off-target activity for CRISPR guide RNAs. | Nucleic Acids Res | 2024 | 39275984 | PubTator, text mining | PubMed |
| Molecular precision medicine: Multi-omics-based stratification model for acute myeloid leukemia. | Heliyon | 2024 | 39263156 | PubTator, text mining | PubMed |
| Case report: Dual-targeted BCMA and CS1 CAR-T-cell immunotherapy in recurrent and refractory extramedullary multiple myeloma. | Front Immunol | 2024 | 39139556 | PubTator, text mining | PubMed |
| Association of serum lipid profile and other systemic risk factors with retinal hard exudates in diabetic retinopathy. | Int Ophthalmol | 2024 | 39095678 | PubTator, text mining | PubMed |
| Integrated multi-omics analysis and machine learning to refine molecular subtypes, prognosis, and immunotherapy in lung adenocarcinoma. | Funct Integr Genomics | 2024 | 38935217 | PubTator, text mining | PubMed |
| CS1 Expression Pattern in NK Cells and Correlated Factors in Plasma Cell dyscrasias: Implications for Elotuzumab Therapy and CAR-T Efficacy. | J Cancer | 2024 | 38706917 | PubTator, text mining | PubMed |
| Micro-RNA-371a-3p in Germ Cell Testicular Tumors on Diagnosis: A Prospective Case-Control Study in Turkish Population. | Urol J | 2024 | 38629199 | PubTator, text mining | PubMed |
| Investigating the impact of regulatory B cells and regulatory B cell-related genes on bladder cancer progression and immunotherapeutic sensitivity. | J Exp Clin Cancer Res | 2024 | 38566204 | PubTator, text mining | PubMed |
| Identification of prognostic biomarkers of smoking-related lung cancer. | J Thorac Dis | 2024 | 38505085 | PubTator, text mining | PubMed |
| Excitation characteristics of circumferential SH guided waves in steel pipes generated by EMATs with few-cycle PPM. | Ultrasonics | 2024 | 38377829 | PubTator, text mining | PubMed |
| Natural carboxyterminal truncation of human CXCL10 attenuates glycosaminoglycan binding, CXCR3A signaling and lymphocyte chemotaxis, while retaining angiostatic activity. | Cell Commun Signal | 2024 | 38308278 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1442/papers?page=4